Overview
Status
Active
Registry date
2006-08-30
Share capital
550,000.00 PLN
Registered address
Wiejska 5, 05-250 Radzymin, Poland
Financials
Revenue history (in k)
From the notes
| Profit allocation | Loss to be covered | |
| Related parties | 1 items |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 83 days late).
- 202522/06/2026
- 202418/06/2025
- 202313/06/2024
- 202207/06/2023
- 202106/10/2022
- 202026/03/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations223 / 231
Top 97%
Results vs industry
Revenue
This companyUSD 291.53MedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD -22.55kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 3.38kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 98.90kMedianUSD 897.46kAverageUSD 31.52m
Industry
Authorized Representatives
Jakub Emil Kiska – Management Board Member
Tomasz Mirosław Kiska – President of the Management Board
Manner of representation
The company is represented by two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Kamil Dawid Kiskaage 31 | 55 | $14,856.83 | 10% |
Elżbieta Renata Kołodziejage 60 | 495 | $133,711.51 | 90% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2006-10-26.
79 1020 1026 0000 1302 0681 3127- 87 1020 1026 0000 1502 0681 3176
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 3, 2025 | Call to creditors | |
| Nov 18, 2024 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BiotonS.A. | $72,911,351.08 | bioton.com | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| VipharmS.A. | $30,660,173.61 | vipharm.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-12-29 | Share capital reduction (1,100,000.00 PLN → 550,000.00 PLN) | |
| 2022-06-08 | Business resumed | |
| 2019-10-01 | Business suspended | |
| 2019-08-27 | Business resumed | |
| 2017-03-31 | Business suspended |
FAQ
Last updated: 2026-06-22